Obesity Clinical Trial
Official title:
Beverage Choice and Lifestyle Modification in Overweight Youth
| Verified date | November 2011 |
| Source | University of Pennsylvania |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Institutional Review Board |
| Study type | Interventional |
The rise in childhood overweightness and concomitant increase in chronic disease risk warrants exploration into the effectiveness of interventions targeting the eating and activity habits of overweight youth. This research study developed and tested a "Beverage Choice and Lifestyle Modification" (BCLM) intervention for 4 to 8 year old children who are at-risk for being overweight or are overweight and who consume large amounts of sugar sweetened beverages and juice. The overall study objectives were to test the acceptability and effectiveness of the BCLM intervention for improving the weight status, energy (kcal) intake, beverage selections and beverage preferences of children in targeted age and BMI group. The investigators hypothesized that those children randomized to the BCLM group will show greater improvements in weight and Body Mass Index (BMI) status, beverage choices,and energy intake than those assigned to our Nutrition Education (NE) group.
| Status | Completed |
| Enrollment | 65 |
| Est. completion date | January 2011 |
| Est. primary completion date | December 2010 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Both |
| Age group | 4 Years to 8 Years |
| Eligibility |
Inclusion Criteria: - Ages 4-8 years old - BMI=85th percentile (based on age and sex) - consumes large (=16 oz.day) sugar sweetened beverages Exclusion Criteria: - Child has a serious medical condition - Signs of elevated psychopathology are present, as assessed by the Child Behavior Checklist (CBCL) - Parent demonstrates elevated psychiatric problems or eating disorders - Failure of parent or child to meet BMI criteria |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| United States | University of Pennsylvania Center for Weight and Eating Disorders | Philadelphia | Pennsylvania |
| Lead Sponsor | Collaborator |
|---|---|
| University of Pennsylvania | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Body Mass Index (BMI) | Change in BMI will be measured from baseline to end of treatment (month 6). | Baseline and Month 6 | No |
| Primary | Body Mass Index z-score (BMI-z) | Change in BMI-z will be measured from baseline to end of treatment (month 6). | Baseline and month 6 | No |
| Primary | Body Mass Index Percentile (BMI%) | Change in BMI% will be measured from baseline to end of treatment (month 6). | Baseline and Month 6 | No |
| Primary | Child percent overweight | Change in child percent overweight will be measured from baseline to end of treatment (month 6). | Baseline and Month 6 | No |
| Primary | Waist Circumference | Change in waist circumference will be measured from baseline to end of treatment (month 6). | Baseline to Month 6 | No |
| Primary | Energy (kcal) intake | Change in energy intake (kcals/day) will be measured from baseline to end of treatment (month 6) using 3-day food diaries. | Baseline to Month 6 | No |
| Primary | Sugar-sweetened beverage intake | Change in sugar-sweetened beverage intake will be measured from baseline to end of treatment (month 6). | Baseline to Month 6 | No |
| Primary | Treatment acceptance and satisfaction | Overall treatment acceptance and satisfaction will be measured at end of treatment. | Month 6 | No |
| Secondary | Child preferences and motivation for sugar-sweetened beverages | Change in child preference and motivation for sugar-sweetened beverages will be measured from baseline to month 6 using a computerized behavioral choice task assessment. | Baseline and Month 6 | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |